4-145639578-GGTCA-G
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PVS1_StrongPM2PP3PP5_Very_Strong
The NM_172250.3(MMAA):c.439+4_439+7del variant causes a splice donor, splice donor region, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000757 in 1,453,972 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_172250.3 splice_donor, splice_donor_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMAA | NM_172250.3 | c.439+4_439+7del | splice_donor_variant, splice_donor_region_variant, intron_variant | ENST00000649156.2 | NP_758454.1 | |||
MMAA | NM_001375644.1 | c.439+4_439+7del | splice_donor_variant, splice_donor_region_variant, intron_variant | NP_001362573.1 | ||||
MMAA | XM_011531684.4 | c.439+4_439+7del | splice_donor_variant, splice_donor_region_variant, intron_variant | XP_011529986.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMAA | ENST00000649156.2 | c.439+4_439+7del | splice_donor_variant, splice_donor_region_variant, intron_variant | NM_172250.3 | ENSP00000497008 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000757 AC: 11AN: 1453972Hom.: 0 AF XY: 0.00000554 AC XY: 4AN XY: 721994
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Methylmalonic aciduria, cblA type Pathogenic:2Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Dec 27, 2023 | - - |
Uncertain significance, flagged submission | clinical testing | Counsyl | Jul 27, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 23, 2023 | This sequence change falls in intron 2 of the MMAA gene. It does not directly change the encoded amino acid sequence of the MMAA protein. It affects a nucleotide within the consensus splice site. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with cobalamin A deficiency (PMID: 15523652, 31497484). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as c.439+1_4del. ClinVar contains an entry for this variant (Variation ID: 549964). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at